| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 04/01/2008 | US7351724 fewer side effects; 2-keto-oxadiazole derivatives; 7-phenyl-1-[5-(pyridin-2-yl)-1,3,4-oxadiazol-2-yl]-heptan-1-one; |
| 04/01/2008 | US7351720 chemokine receptor (CCR) inhibitors for treating allergic or inflammatory diseases such as asthma or rheumatoid arthritis, multiple sclerosis, inflammatory bowel diseases; 2-((p-fluorobenzyl)piperidinylmethyl)cyclohexylureas of given formula |
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | US7351712 Inhibitors of the FAK (focal adhesion kinase) protein tyrosine kinases, antiproliferative, antitumor; for example 5-{4-[(1-Hydroxy-cyclopentylmethyl)-amino]-5-trifluoromethyl-pyrimidin-2-ylamino}-1,3-dihydro-indol-2-one |
| 04/01/2008 | US7351706 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 04/01/2008 | US7351705 Carboxylic acid compounds and a pharmaceutical agent comprising the compound as the active ingredient |
| 04/01/2008 | US7351700 4-(2-Hexylsulfanyl-6-methyl-pyrimidin-4-ylmethyl)-morpholine; antidepressant, anxiolytic agent, cognition activator; epilepsy, schizophrenia, spasticity and skeletal muscle rigidity, spinal cord injury, multiple sclerosis, amyotrophic lateral sclerosis, neuropathic pain |
| 04/01/2008 | CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 03/27/2008 | WO2008036642A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008036379A2 Serine hydrolase inhibitors |
| 03/27/2008 | WO2008035737A1 4-nitrobenzoyl derivative having sulfoxyimino group and herbicide for rice plant |
| 03/27/2008 | WO2008035726A1 Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same |
| 03/27/2008 | WO2008035209A2 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity |
| 03/27/2008 | WO2008015693A8 Process for the preparation of mycophenolate mofetil |
| 03/27/2008 | WO2008010934A3 Triazolyl phenyl benzenesulfonamides |
| 03/27/2008 | WO2008008431A3 Heteroaryl sulfonamides and ccr2/ccr9 |
| 03/27/2008 | WO2008002674A3 Bicyclic compositions and methods for modulating a kinase cascade |
| 03/27/2008 | WO2008002671A3 Metalloprotease inhibitors |
| 03/27/2008 | WO2007136668A9 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists |
| 03/27/2008 | WO2007136573A3 Antidiabetic bicyclic compounds |
| 03/27/2008 | WO2007109334B1 Sip receptor modulating compounds and use thereof |
| 03/27/2008 | WO2007094513A3 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension |
| 03/27/2008 | WO2007020411A8 Amide derivatives |
| 03/27/2008 | WO2006125621A8 Substituted piperidines as renin inhibitors |
| 03/27/2008 | US20080076918 Quinoxaline compounds |
| 03/27/2008 | US20080076815 Sulfonamide or sulfonimide functional indazole or indole compounds such as N-[3-[2-[2-(3-methylindazol-6-yloxy)ethylamino]-1-hydryoxyethyl]phenyl]methanesulfonamide; diabetes, obesity, hyperlipidemia and urinary incontinence |
| 03/27/2008 | US20080076810 Benzoureas Having Anti-Diabetic Activity |
| 03/27/2008 | US20080076771 Thrombopoietin Receptor Agonists |
| 03/27/2008 | US20080076768 Pharmaceutical compounds |
| 03/27/2008 | US20080076767 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic |
| 03/27/2008 | US20080076759 Therapeutic Heterocyclic Compounds 507 |
| 03/27/2008 | US20080076725 less hygroscopic |
| 03/27/2008 | US20080075892 capable of functioning as a lamda/4 plate applicable to a broader viewing angle; discotic; phenylcyclopropylcarbonyloxy-substituted triphenylene ring compounds |
| 03/27/2008 | DE102006043443A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 03/27/2008 | DE102006042143A1 Neue substituierte Bipyridin-Derivate und ihre Verwendung New substituted bipyridine derivatives and their use |
| 03/27/2008 | CA2664411A1 Platelet adp receptor inhibitors |
| 03/27/2008 | CA2664152A1 Serine hydrolase inhibitors |
| 03/27/2008 | CA2663057A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1902052A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 03/26/2008 | EP1902051A1 Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 03/26/2008 | EP1902050A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 03/26/2008 | EP1902049A2 Non-steroidal progesterone receptor modulators |
| 03/26/2008 | EP1902048A1 Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents |
| 03/26/2008 | EP1902046A1 Piperidine derivatives useful as histamine h3 antagonists |
| 03/26/2008 | EP1902032A1 Pharmaceutical compounds |
| 03/26/2008 | EP1902028A2 Histamine h3 receptor antagonists |
| 03/26/2008 | EP1902026A2 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm) |
| 03/26/2008 | EP1902025A1 Kinase inhibitors |
| 03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/26/2008 | EP1901608A1 Substituted arylpyrazoles as parasiticidal agents |
| 03/26/2008 | EP1660460B1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
| 03/26/2008 | EP1583763B1 Benzoazolylpiperazine derivatives having vr1-antagonist activity |
| 03/26/2008 | EP1031573B1 Novel benzoylpyrazole compounds, intermediates, and herbicides |
| 03/26/2008 | CN101151263A Substituted piperidines as renin inhibitors |
| 03/26/2008 | CN101151262A Substituted piperidines |
| 03/26/2008 | CN101151261A Pyrimidine compounds having tie2 (TEK) inhibitory activity |
| 03/26/2008 | CN101151260A Benzimidazole derivative and use as angiotensin ii antagonist |
| 03/26/2008 | CN101151259A Heteroaryl urea derivatives useful for inhibiting CHKI |
| 03/26/2008 | CN101151249A Cyclopentapyridine and tetrahydroquinoline derivatives |
| 03/26/2008 | CN101151247A 3,4,5-substituted piperidines as renin inhibitors |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/26/2008 | CN100376565C Method for preparing fused oxazinones |
| 03/26/2008 | CN100376560C New tricyclic compounds and their use as medicine, process for their preparation and pharmaceutical compositions containing them |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348427 Substituted with an amido heterocylic groups; infection by Gram-positive bacteria. |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348425 Inhibitors of HCV replication |
| 03/25/2008 | US7348357 bactericide; derivatives of pseudopeptide Andrimid in which beta-phenylalanine amide is replaced by heteroaromatic or substituted aromatic amide; N-{(1S)-3-[((1S)-1-{[(3R,4S)-1,4-Dimethyl-2,5-dioxo-3-pyrrolidinyl]carbonyl}-2-methylpropyl)amino]-3-oxo-1-phenylpropyl}-2-pyridinecarboxamide; antibiotics |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348337 heterocyclic oxo amides such as 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione, used as viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | CA2359987C 2-amino-benzoxazinone derivatives for the treatment of obesity |
| 03/25/2008 | CA2268394C New heterocyclylmethyl-substituted pyrazol derivates |
| 03/20/2008 | WO2008034032A2 Beta-lactam cannabinoid receptor modulators |
| 03/20/2008 | WO2008033854A1 Certain substituted amides, method of making, and method of use thereof |
| 03/20/2008 | WO2008033764A2 Quinazolinone and isoquinolinone acetamide derivatives |
| 03/20/2008 | WO2008033513A1 ISOXAZOLINE ALPHA 1a/1d ADRENORECEPTOR ANTAGONISTS |
| 03/20/2008 | WO2008032191A2 Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators |
| 03/20/2008 | WO2008032171A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
| 03/20/2008 | WO2008032089A1 4-benzimidaz0lyl-2-m0rph0lin0-6-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032086A1 2-benzimidazolyl-6-morpholino-4-phenylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032072A1 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032064A1 Pyrimidine derivatives |
| 03/20/2008 | WO2008032036A1 6-benzimidaz0lyl-2-m0rph0lin0-4- (azetidine, pyrrolidine, piperidine or azepine) pyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008032033A1 4-benzimidazolyl-2-morpholino-6-piperazinylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
| 03/20/2008 | WO2008031743A1 Heterocyclic bridged biphenyls and their use in oleds |
| 03/20/2008 | WO2008031594A1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors |
| 03/20/2008 | WO2008031227A1 Diaryl piperidine compounds as calcium channel blockers |
| 03/20/2008 | WO2008015189A3 Fungicidal n-cycloalkyl-carboxamide derivatives |
| 03/20/2008 | WO2008014247A3 4 -arylalkoxymethyl-4- phenyl piperidines and their use as neurokinin receptor antagonists for the treatment of cns disorders |
| 03/20/2008 | WO2008009750A3 Macrocyclic compounds useful as bace inhibitors |
| 03/20/2008 | WO2007133983A3 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/20/2008 | WO2006094187A3 Phthalazine, aza- and diaza-phthalazine compounds and methods of use |
| 03/20/2008 | US20080071083 Methods for minimizing thioamide impurities |
| 03/20/2008 | US20080070948 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain |
| 03/20/2008 | US20080070928 Novel 2-Heteroaryl-Substituted Benzimidazole Derivative |
| 03/20/2008 | US20080070927 Substituted Heterocyclic Compounds |